
enGene Holdings Inc.
ENGNHealthcare|Biotechnology|CA
$1.75
+0.07 (+4.17%)
DCF Value
$0.28
Tangible Book / Share
$3.30
Cash / Share
$3.82
Ownership Breakdown
36.6%
Float
67.0M
Shares Outstanding
24.5M
Float Shares
Major Holders (40)
Combined: 222.2%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Perceptive Life Sciences Master Fund, Ltd. | Corporation | 9.99% | 6,770,605 | Nov 18, 2025 | 13D/G |
| Perceptive Advisors LLC | Investment adviser | 9.99% | 6,770,605 | Nov 18, 2025 | 13D/G |
| Joseph Edelman | Individual | 9.99% | 6,770,605 | Nov 18, 2025 | 13D/G |
| Bong Y Koh | Individual | 9.90% | 5,046,414 | Feb 14, 2025 | 13D/G |
| Raymond Debbane | Individual | 9.30% | 6,256,662 | Aug 13, 2026 | 13D/G |
| Invus Public Equities, L.P. | Partnership | 8.20% | 5,481,984 | Aug 13, 2026 | 13D/G |
| Invus Global Management, LLC | Other | 8.20% | 5,481,984 | Aug 13, 2026 | 13D/G |
| Invus Public Equities Advisors, LLC | Other | 8.20% | 5,481,984 | Aug 13, 2026 | 13D/G |
| Siren, L.L.C. | Other | 8.20% | 5,481,984 | Aug 13, 2026 | 13D/G |
| Shah, Nimish | Individual | 8.10% | 3,565,841 | Nov 14, 2024 | 13D/G |
| Koh, Bong | Individual | 8.10% | 3,565,841 | Nov 14, 2024 | 13D/G |
| BML Investment Partners, L.P. | Partnership | 7.80% | 5,225,000 | May 13, 2026 | 13D/G |
| Venrock Healthcare Capital Partners EG, L.P. | Partnership | 7.10% | 4,771,414 | Feb 17, 2026 | 13D/G |
| VHCP Co-Investment Holdings III, LLC | Other | 7.10% | 4,771,414 | Feb 17, 2026 | 13D/G |
| Venrock Healthcare Capital Partners III, L.P. | Partnership | 7.10% | 4,771,414 | Feb 17, 2026 | 13D/G |
| Bong Y. Koh | Individual | 7.10% | 4,771,414 | Feb 17, 2026 | 13D/G |
| Nimish Shah | Individual | 7.10% | 4,771,414 | Feb 17, 2026 | 13D/G |
| VHCP Management EG, LLC | Other | 7.10% | 4,771,414 | Feb 17, 2026 | 13D/G |
| VHCP Management III, LLC | Other | 7.10% | 4,771,414 | Feb 17, 2026 | 13D/G |
| Bihua Chen | HC, IN | 5.97% | 4,000,000 | Feb 17, 2026 | 13D/G |
| Cormorant Asset Management, LP | IA, PN | 5.97% | 4,000,000 | Feb 17, 2026 | 13D/G |
| BVF GP Holdings LLC | Other | 5.50% | 2,861,375 | Jan 29, 2025 | 13D/G |
| BVF I GP LLC | Other | 3.10% | 1,597,986 | Jan 29, 2025 | 13D/G |
| Biotechnology Value Fund L P | Partnership | 3.10% | 1,597,986 | Jan 29, 2025 | 13D/G |
| Omega Fund VII GP Manager, Ltd. | Other | 3.10% | 1,397,859 | Nov 14, 2024 | 13D/G |
| Omega Fund VII, L.P. | Partnership | 3.10% | 1,397,859 | Nov 14, 2024 | 13D/G |
| Omega Fund VII GP, L.P. | Partnership | 3.10% | 1,397,859 | Nov 14, 2024 | 13D/G |
| Claudio Nessi | Individual | 3.10% | 1,397,859 | Nov 14, 2024 | 13D/G |
| Otello Stampacchia | Individual | 3.10% | 1,397,859 | Nov 14, 2024 | 13D/G |
| Francesco Draetta | Individual | 3.10% | 1,397,859 | Nov 14, 2024 | 13D/G |
| Adage Capital Management, L.P. | IA, PN | 3.00% | 1,528,768 | Feb 12, 2025 | 13D/G |
| Robert Atchinson | HC, IN | 3.00% | 1,528,768 | Feb 12, 2025 | 13D/G |
| Phillip Gross | HC, IN | 3.00% | 1,528,768 | Feb 12, 2025 | 13D/G |
| Biotechnology Value Fund II LP | Partnership | 2.50% | 1,263,389 | Jan 29, 2025 | 13D/G |
| BVF II GP LLC | Other | 2.50% | 1,263,389 | Jan 29, 2025 | 13D/G |
| Yue Tang | Individual | 2.23% | 1,492,898 | Feb 17, 2026 | 13D/G |
| Kynam Capital Management, LP | Investment adviser | 2.23% | 1,492,898 | Feb 17, 2026 | 13D/G |
| Kynam Capital Management GP, LLC | Other | 2.23% | 1,492,898 | Feb 17, 2026 | 13D/G |
| BVF Partners L P/Il | IA, PN | 1.80% | 945,402 | Jan 29, 2025 | 13D/G |
| BVF Inc/Il | Corporation | 1.80% | 945,402 | Jan 29, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 3,579,102 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Grossman William | director, officer: Interim Chief Medical Officer | Sep 22, 2026 | BUY | 5,102 | $1.97 | $10.1K | Form 4 |
| Chinoporos Constantine | Interim Chief Business Officer | Jul 16, 2026 | OTHER | 75,000 | $1.75 | $131.3K | Form 4 |
| Richton Kathleen P. | SVP, Finance and Treasurer | Jul 16, 2026 | OTHER | 0 | — | — | Form 4 |
| Richton Kathleen P. | SVP, Finance and Treasurer | Jul 16, 2026 | OTHER | 45,000 | $7.39 | $332.6K | Form 4 |
| Richton Kathleen P. | SVP, Finance and Treasurer | Jul 16, 2026 | OTHER | 13,900 | $9.53 | $132.5K | Form 4 |
| Richton Kathleen P. | SVP, Finance and Treasurer | Jul 16, 2026 | OTHER | 105,000 | $1.75 | $183.8K | Form 4 |
| Astley-Sparke Philip | director | Jun 16, 2026 | AWARD | 31,000 | $1.75 | $54.3K | Form 4 |
| BRUNK GERALD A | director | Jun 16, 2026 | AWARD | 31,000 | $1.75 | $54.3K | Form 4 |
| Glickman Richard M | director | Jun 16, 2026 | AWARD | 31,000 | $1.75 | $54.3K | Form 4 |
| Grossman William | director, officer: Interim Chief Medical Officer | Jun 16, 2026 | AWARD | 200,000 | $1.75 | $350.0K | Form 4 |
| Grossman William | director, officer: Interim Chief Medical Officer | Jun 16, 2026 | AWARD | 31,000 | $1.75 | $54.3K | Form 4 |
| HASTINGS PAUL J | director | Jun 16, 2026 | AWARD | 31,000 | $1.75 | $54.3K | Form 4 |
| Heffernan Michael Thomas | director | Jun 16, 2026 | AWARD | 31,000 | $1.75 | $54.3K | Form 4 |
| Joustra Wouter | director | Jun 16, 2026 | AWARD | 31,000 | $1.75 | $54.3K | Form 4 |
| Zoth Lota S. | director | Jun 16, 2026 | AWARD | 31,000 | $1.75 | $54.3K | Form 4 |
| CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Jan 30, 2026 | AWARD | 195,000 | $9.53 | $1.9M | Form 4 |
| Giguere Lee | Chief Legal Ofc. and Corp Secy | Jan 30, 2026 | AWARD | 195,000 | $9.53 | $1.9M | Form 4 |
| Nichols Alexander Julian | Chief Strategy & Ops. Ofc | Jan 30, 2026 | AWARD | 195,000 | $9.53 | $1.9M | Form 4 |
| Daws D. Ryan | Chief Financial Officer | Jan 30, 2026 | AWARD | 220,000 | $9.53 | $2.1M | Form 4 |
| Cooper Ronald Harold Wilfred | director, officer: CEO & President | Jan 30, 2026 | AWARD | 801,000 | $9.53 | $7.6M | Form 4 |
| Connolly Joan | Chief Technology Officer | Jan 30, 2026 | AWARD | 195,000 | $9.53 | $1.9M | Form 4 |
| Boyd Matthew Ross | Chief Regulatory Officer | Jan 30, 2026 | AWARD | 195,000 | $9.53 | $1.9M | Form 4 |
| Buck Jill | Chief Development Officer | Jan 30, 2026 | AWARD | 195,000 | $9.53 | $1.9M | Form 4 |
| Sweiti Hussein | Chief Medical Officer | Sep 30, 2025 | AWARD | 600,000 | $6.83 | $4.1M | Form 4 |
| Sweiti Hussein | Sep 29, 2025 | OTHER | 0 | — | — | Form 4 | |
| Boyd Matthew Ross | Chief Regulatory Officer | Jul 8, 2025 | AWARD | 100,000 | $3.83 | $383.0K | Form 4 |
| Boyd Matthew Ross | Chief Regulatory Officer | Jul 8, 2025 | OTHER | 0 | — | — | Form 4 |
| Boyd Matthew Ross | Chief Regulatory Officer | Jul 8, 2025 | OTHER | 51,000 | $7.39 | $376.9K | Form 4 |
| Boyd Matthew Ross | Chief Regulatory Officer | Jul 8, 2025 | OTHER | 68,000 | $6.60 | $448.8K | Form 4 |
| Astley-Sparke Philip | director | Jul 8, 2025 | AWARD | 45,000 | $3.83 | $172.3K | Form 4 |
| Heffernan Michael Thomas | director | Jul 8, 2025 | AWARD | 45,000 | $3.83 | $172.3K | Form 4 |
| Grossman William | director | Jul 8, 2025 | AWARD | 45,000 | $3.83 | $172.3K | Form 4 |
| Buck Jill | Chief Development Officer | Jul 8, 2025 | AWARD | 100,000 | $3.83 | $383.0K | Form 4 |
| Heffernan Michael Thomas | Jul 8, 2025 | OTHER | 0 | — | — | Form 4 | |
| Astley-Sparke Philip | director | Jul 8, 2025 | OTHER | 0 | — | — | Form 4 |
| Grossman William | Jul 8, 2025 | OTHER | 0 | — | — | Form 4 | |
| Buck Jill | Chief Development Officer | Jul 8, 2025 | OTHER | 68,000 | $6.60 | $448.8K | Form 4 |
| Buck Jill | Chief Development Officer | Jul 8, 2025 | OTHER | 51,000 | $7.39 | $376.9K | Form 4 |
| Zoth Lota S. | director | Jun 16, 2025 | AWARD | 22,500 | $3.31 | $74.5K | Form 4 |
| Pott Amy | Chief Global Comm. Ofc. | Jun 16, 2025 | AWARD | 400,000 | $3.31 | $1.3M | Form 4 |
| Joustra Wouter | director | Jun 16, 2025 | AWARD | 22,500 | $3.31 | $74.5K | Form 4 |
| HASTINGS PAUL J | director | Jun 16, 2025 | AWARD | 22,500 | $3.31 | $74.5K | Form 4 |
| Glickman Richard M | director | Jun 16, 2025 | AWARD | 22,500 | $3.31 | $74.5K | Form 4 |
| BRUNK GERALD A | director | Jun 16, 2025 | AWARD | 22,500 | $3.31 | $74.5K | Form 4 |
| Bos Jasper | director | Jun 16, 2025 | AWARD | 22,500 | $3.31 | $74.5K | Form 4 |
| Pott Amy | May 27, 2025 | OTHER | 0 | — | — | Form 4 | |
| Pruthi Raj Som | Chief Medical Officer | Jan 29, 2025 | AWARD | 280,000 | $7.39 | $2.1M | Form 4 |
| Nichols Alexander Julian | Chief Strategy & Ops. Ofc | Jan 29, 2025 | AWARD | 250,000 | $7.39 | $1.8M | Form 4 |
| Giguere Lee | Chief Legal Ofc. and Corp Secy | Jan 29, 2025 | AWARD | 250,000 | $7.39 | $1.8M | Form 4 |
| Daws D. Ryan | Chief Financial Officer | Jan 29, 2025 | AWARD | 280,000 | $7.39 | $2.1M | Form 4 |
| CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Jan 29, 2025 | AWARD | 250,000 | $7.39 | $1.8M | Form 4 |
| Cooper Ronald Harold Wilfred | director, officer: CEO & President | Jan 29, 2025 | AWARD | 850,000 | $7.39 | $6.3M | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Oct 30, 2024 | BUY | 561,797 | $8.90 | $5.0M | Form 4 |
| CHEUNG ANTHONY TZEYEW | Chief Scientific Officer | Oct 21, 2024 | AWARD | 100,000 | $9.83 | $983.0K | Form 4 |
| Connolly Joan | Chief Technology Officer | Oct 21, 2024 | AWARD | 210,000 | $9.83 | $2.1M | Form 4 |
| Connolly Joan | Oct 21, 2024 | OTHER | 0 | — | — | Form 4 | |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Oct 8, 2024 | BUY | 800 | $6.60 | $5.3K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Oct 7, 2024 | BUY | 11,844 | $6.55 | $77.5K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Oct 4, 2024 | BUY | 5,997 | $6.54 | $39.2K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Oct 3, 2024 | BUY | 5,769 | $6.48 | $37.4K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Oct 2, 2024 | BUY | 10,153 | $6.37 | $64.7K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Oct 1, 2024 | BUY | 35,279 | $6.44 | $227.2K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Sep 30, 2024 | BUY | 341,332 | $6.34 | $2.2M | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Sep 27, 2024 | BUY | 3,243 | $6.38 | $20.7K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Sep 27, 2024 | BUY | 38,396 | $5.94 | $228.0K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Dec 29, 2023 | BUY | 9,620 | $9.09 | $87.5K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Dec 29, 2023 | BUY | 400 | $8.30 | $3.3K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Dec 28, 2023 | BUY | 5,050 | $7.69 | $38.8K | Form 4 |
| Forbion Growth Opportunities Fund I Cooperatief U.A. | 10 percent owner | Dec 27, 2023 | BUY | 2,750 | $7.17 | $19.7K | Form 4 |
| Cooper Ronald Harold Wilfred | director, officer: Chief Executive Officer | Sep 27, 2024 | BUY | 10,000 | $5.70 | $57.0K | Form 4 |
| Pruthi Raj Som | Chief Medical Officer | Jul 24, 2024 | AWARD | 110,000 | $8.65 | $951.5K | Form 4 |
| Pruthi Raj Som | Chief Medical Officer | Jul 22, 2024 | OTHER | 125,000 | $14.80 | $1.9M | Form 4 |
| Cooper Ronald Harold Wilfred | director, officer: Chief Executive Officer | Jul 22, 2024 | AWARD | 1,250,000 | $8.81 | $11.0M | Form 4 |
| Cooper Ronald Harold Wilfred | Jul 22, 2024 | OTHER | 0 | — | — | Form 4 | |
| Zoth Lota S. | director | Jun 15, 2024 | AWARD | 20,000 | $9.00 | $180.0K | Form 4 |
| HASTINGS PAUL J | director | Jun 15, 2024 | AWARD | 40,000 | $9.00 | $360.0K | Form 4 |
| Joustra Wouter | director | Jun 15, 2024 | AWARD | 40,000 | $9.00 | $360.0K | Form 4 |
| Glickman Richard M | director | Jun 15, 2024 | AWARD | 20,000 | $9.00 | $180.0K | Form 4 |
| Bos Jasper | director | Jun 15, 2024 | AWARD | 20,000 | $9.00 | $180.0K | Form 4 |
| BRUNK GERALD A | director | Jun 15, 2024 | AWARD | 20,000 | $9.00 | $180.0K | Form 4 |
| Glickman Richard M | director | May 28, 2024 | OPTION EX. | 120 | $0.89 | $106.80 | Form 4 |
| Glickman Richard M | director | May 28, 2024 | OPTION EX. | 120 | $0.89 | $106.80 | Form 4 |
| HASTINGS PAUL J | May 15, 2024 | OTHER | 0 | — | — | Form 4 | |
| Joustra Wouter | May 15, 2024 | OTHER | 0 | — | — | Form 4 | |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10 percent owner | Apr 18, 2024 | SELL | 4,575 | $15.01 | $68.7K | Form 4 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10 percent owner | Apr 19, 2024 | SELL | 100 | $15.00 | $1.5K | Form 4 |
| FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC | 10 percent owner | Apr 22, 2024 | SELL | 47,854 | $15.00 | $717.8K | Form 4 |
| Zoth Lota S. | director | Mar 21, 2024 | AWARD | 40,000 | $17.80 | $712.0K | Form 4 |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | Mar 18, 2024 | OPTION EX. | 52,940 | $0.89 | $47.1K | Form 4 |
| CHEUNG ANTHONY TZEYEW | Chief Technology Officer | Mar 18, 2024 | OPTION EX. | 52,940 | $0.89 | $47.1K | Form 4 |
| Giguere Lee | Chief Legal Ofc. and Corp Secy | Mar 15, 2024 | AWARD | 225,000 | $16.85 | $3.8M | Form 4 |
| BRUNK GERALD A | director, 10 percent owner: | Feb 20, 2024 | AWARD | 644,965 | $10.00 | $6.4M | Form 4 |
| BRUNK GERALD A | director, 10 percent owner: | Feb 20, 2024 | AWARD | 155,035 | $10.00 | $1.6M | Form 4 |
| Lumira Capital Investment Management Inc. | 10 percent owner | Feb 20, 2024 | AWARD | 644,965 | $10.00 | $6.4M | Form 4 |
| Lumira Capital Investment Management Inc. | 10 percent owner | Feb 20, 2024 | AWARD | 155,035 | $10.00 | $1.6M | Form 4 |
| Giguere Lee | Jan 29, 2024 | OTHER | 0 | — | — | Form 4 | |
| Zoth Lota S. | Dec 18, 2023 | OTHER | 0 | — | — | Form 4 | |
| BRYCE RICHARD PAUL | Chief Medical Officer | Nov 30, 2023 | AWARD | 153,000 | $7.66 | $1.2M | Form 4 |
| Daws D. Ryan | Chief Financial Officer | Nov 30, 2023 | AWARD | 232,000 | $7.66 | $1.8M | Form 4 |
| Daws D. Ryan | Nov 27, 2023 | OTHER | 0 | — | — | Form 4 |